Cubist Systematic Strategies LLC lifted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 416.1% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,124 shares of the medical instruments supplier’s stock after buying an additional 3,325 shares during the period. Cubist Systematic Strategies LLC’s holdings in Merit Medical Systems were worth $246,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the company. BlackRock Inc. raised its holdings in shares of Merit Medical Systems by 6.2% during the 2nd quarter. BlackRock Inc. now owns 8,567,745 shares of the medical instruments supplier’s stock worth $510,294,000 after buying an additional 502,387 shares in the last quarter. FMR LLC raised its holdings in shares of Merit Medical Systems by 6.1% during the 1st quarter. FMR LLC now owns 1,735,494 shares of the medical instruments supplier’s stock worth $107,306,000 after buying an additional 99,015 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Merit Medical Systems by 65.4% during the 2nd quarter. Invesco Ltd. now owns 971,691 shares of the medical instruments supplier’s stock worth $57,874,000 after buying an additional 384,332 shares in the last quarter. Jennison Associates LLC raised its holdings in shares of Merit Medical Systems by 19.1% during the 2nd quarter. Jennison Associates LLC now owns 934,955 shares of the medical instruments supplier’s stock worth $55,686,000 after buying an additional 150,000 shares in the last quarter. Finally, Conestoga Capital Advisors LLC acquired a new position in shares of Merit Medical Systems during the 2nd quarter worth $51,321,000. 98.70% of the stock is owned by institutional investors.
In other Merit Medical Systems news, CEO Fred P. Lampropoulos sold 40,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $36.86, for a total value of $1,474,400.00. Following the sale, the chief executive officer now owns 1,079,991 shares in the company, valued at approximately $39,808,468.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Fred P. Lampropoulos sold 150,000 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $30.72, for a total value of $4,608,000.00. Following the completion of the sale, the chief executive officer now owns 929,991 shares in the company, valued at approximately $28,569,323.52. The disclosure for this sale can be found here. In the last ninety days, insiders sold 234,530 shares of company stock valued at $7,853,050. Insiders own 4.75% of the company’s stock.
Shares of MMSI opened at $28.46 on Tuesday. Merit Medical Systems, Inc. has a 12-month low of $25.67 and a 12-month high of $65.18. The business has a 50-day simple moving average of $30.49 and a two-hundred day simple moving average of $47.70. The company has a quick ratio of 1.27, a current ratio of 2.42 and a debt-to-equity ratio of 0.48. The stock has a market cap of $1.54 billion, a PE ratio of 16.84, a PEG ratio of 1.47 and a beta of 1.07.
Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.08). Merit Medical Systems had a return on equity of 10.40% and a net margin of 4.10%. The firm had revenue of $255.50 million during the quarter, compared to analyst estimates of $258.58 million. During the same period in the previous year, the company earned $0.43 EPS. Merit Medical Systems’s revenue for the quarter was up 13.7% on a year-over-year basis. On average, equities research analysts expect that Merit Medical Systems, Inc. will post 1.78 EPS for the current year.
About Merit Medical Systems
Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.
Featured Article: Quick Ratio
Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.